ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
17.33
-1.25 (-6.73%)
At close: Oct 7, 2026, 4:00 PM EDT
17.22
-0.11 (-0.63%)
After-hours: Oct 7, 2026, 7:30 PM EDT
ADARx Pharmaceuticals Market Cap
ADARx Pharmaceuticals has a market cap or net worth of $1.94 billion as of October 7, 2026. That makes ADARx Pharmaceuticals the world's 6,900th most valuable company and 1,796th in the United States.
Market Cap
1.94B
Enterprise Value
1.52B
1-Year Change
n/a
Global Rank
Country Rank
#1,796 United States
Category
ChartMarket Cap Chart
Since the IPO on September 25, 2026, ADARx Pharmaceuticals's market cap has increased from $1.74B to $1.94B, an increase of 11.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.94B | -6.73% |
| Oct 6, 2026 | 2.08B | -2.47% |
| Oct 5, 2026 | 2.13B | 4.38% |
| Oct 2, 2026 | 2.05B | -6.60% |
| Oct 1, 2026 | 2.19B | -2.01% |
| Sep 30, 2026 | 2.23B | -3.37% |
| Sep 29, 2026 | 2.31B | 2.71% |
| Sep 28, 2026 | 2.25B | 29.57% |
| Sep 25, 2026 | 1.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 1.99B |
| Lakefront Biotherapeutics NV | 1.97B |
| Fortrea Holdings | 1.96B |
| Mineralys Therapeutics | 1.96B |
| Vir Biotechnology | 1.94B |
| Maravai LifeSciences Holdings | 1.93B |
| Structure Therapeutics | 1.91B |
| Agios Pharmaceuticals | 1.90B |